| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |